Repotrectinib is a small-molecule tyrosine kinase inhibitor used in kinase signaling and cancer biology research. Also known as TPX-0005, it targets ROS1 and tropomyosin receptor kinases (TRKs), supporting studies of oncogenic signaling, kinase inhibition, and drug resistance.
Key Features and Benefits
- Tyrosine Kinase Inhibitor: Repotrectinib inhibits selected receptor tyrosine kinases specifically involved in cellular signaling and cancer biology.
- ROS1 Inhibition: Repotrectinib supports research into ROS1 kinase activity, ROS1 fusion proteins, and ROS1-driven signaling.
- TRK Inhibition: Targets TRK family kinases encoded by NTRK1, NTRK2, and NTRK3.
- Small-Molecule Inhibitor: Its compact macrocyclic structure specifically supports research involving kinase binding and inhibitor activity.
- Oncogenic Signaling Research: Enables investigation of kinase-driven signaling pathways associated with cellular proliferation and survival.
- Drug Resistance Research: Supports studies of resistance mechanisms and kinase alterations that affect inhibitor response.
- Cancer Biology Research: Provides a research tool for studying ROS1- and NTRK-associated molecular pathways.
Applications
- ROS1 Research: Researchers use Repotrectinib to investigate ROS1 signaling, kinase activity, and ROS1 fusion-driven cellular models.
- NTRK Research: Supports studies involving NTRK1, NTRK2, and NTRK3 signaling and TRK fusion proteins.
- Kinase Inhibition Studies: Enables investigation of receptor tyrosine kinase inhibition and downstream cellular responses.
- Cancer Biology Research: Supports studies of kinase-driven cancer models and associated molecular mechanisms.
- Drug Resistance Research: Enables investigation of resistance-associated kinase mutations and changes in inhibitor sensitivity.
- Cell Signaling Research: Supports studies of signaling pathways downstream of ROS1 and TRK kinases.
- Mechanistic Research: Provides a small-molecule tool specifically for examining kinase-dependent cellular processes and inhibitor responses.
Storage and Handling
- Storage: Store according to the product specification in a tightly sealed container under appropriate conditions. Protect from moisture and excessive heat.
- Handling: Follow standard laboratory procedures for small-molecule research compounds. Prepare and store solutions according to experimental requirements and stability considerations.
Repotrectinib provides a small-molecule platform for studying ROS1 and TRK kinase signaling and specifically supports kinase inhibition, oncogenic signaling, drug resistance, and cancer biology research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
